Most studies in mCRC have reported good concordance in mutational profiles of major signaling pathways, such as KRAS, TP53, APC, PIK3CA, BRAF, and NRAS, between the primary tumor and its metastases, superior to 95% [72,73]. This evidence concerns the gene PIK3CA and neoplasm.